In those studies, the increased circulating levels of FGF21 observed in the patients with tumor might have been due to the increased synthesis and release of FGF21 in tumor cells, or the metabolic disorder of the microenvironment caused by tumor stress35. The gene discussed is FGF21; the disease is neoplasm.